Search

everythinglearnresearchcommunity

for

Search:↓

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Most types of hair loss can regrow naturally, but there are no effective cures for male pattern or age-related hair loss, and only limited options for females.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Finasteride helps reduce heart issues and improves heart function.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Multiple treatments work best for hair loss.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.